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Abstract
Over the past few decades, the emergence of multidrug resistance (MDR) to antibiotics in bacteria has led to
major difficulties in the management of infected patients. At present, there is a serious lack of development of
new antibacterial agents. Mathematical models are one approach to understand how antibiotic usage patterns
may be optimized. However, the classical approach to modeling the emergence of MDR relies on the simplifying
assumption that resistance is acquired at a constant rate. In their model, Obolski and Hadany introduce the notion
of horizontal gene transfer and stress-induced mutation, with antibiotics constituting an environmental stressor of
particular relevance. Finally, from this complex mathematical model, the authors propose predictions for
minimizing MDR in bacteria depending on strategies of antibiotic treatment.
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Background
Over the past few decades, the emergence of bacteria
resistant to multiple antimicrobial agents has led to
major difficulties in the management of infected patients.
This has required significant changes in our approaches
to the use of antibiotics and should lead to new ways of
thinking about the production of effective antibacterial
drugs. Unfortunately, at present, there is a serious lack of
development of new antibacterial agents, specifically con-
cerning Gram-negative bacilli. Programs, supported by
the medical community and government organizations,
have been implemented to limit the emergence of multi-
drug resistance (MDR) to antibiotics: reducing the inap-
propriate use of antibiotics (not treating colonization;
antibiotic use is best suited to the clinical situation) and
improving standards of hygiene to prevent crosstransmis-
sion. It is clear that these measures were not sufficient to
stop the process [1]. Other approaches are possible, such
as modeling the emergence of MDR. In a study by
Obolski and Hadany published in BMC Medicine, the
authors’ objective was to explore the impact of genetic
variation induced by antibiotic stress on the spread of
MDR in a hospital unit [2]. The purpose of such models
is to understand how antibiotic usage patterns may be
optimized.
Clinical importance of the mathematical model
In their rationale, Obolski and Hadany highlighted the
importance of three different strategies (cycling, mixing
and combining) of antibiotic prescribing to minimize the
emergence of MDR. In the cycling regime, antibiotic
treatment is the same for all patients at a given time and
the treatment is periodically switched. In the mixing
strategy, each patient receives a randomly selected drug.
Combining involves administering several antibiotic
treatments to each patient. The authors noted the ability
of each strategy to prevent the risk of emergence of
MDR, indicating that more antibiotics were used in com-
bining than in mixing or cycling. They emphasize that
the classical approach to modeling the emergence of
MDR relies on the simplifying assumption that resistance
is acquired at a constant rate, ignoring recent data on the
effect of environmental stress on mechanisms of acquired
resistance. This erroneous assumption could be the cause
of frequent reservations in the conclusions of these mod-
els. Moreover, the actual effect of a single intervention in
a complex situation is often difficult to grasp [3]. The ori-
ginality in the model used by Obolski and Hadany is to
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introduce the notion of horizontal gene transfer (HGT)
and stress-induced mutation (SIM), antibiotics constitut-
ing an environmental stressor of particular relevance.
The authors justify this hypothesis by showing examples
of stress-induced HGT and SIM for various microorgan-
isms that may be encountered in community-acquired
infections (Streptococcus pneumoniae, Escherichia coli),
nosocomial (Pseudomonas aeruginosa, E. coli) or epi-
demic infections (Vibrio cholerae). The model is used,
but adapted to integrate the concepts of stress-induced
HGT and SIM [4]. The authors also introduce some con-
straints in the model: (i) the bacterial pathogens are
assumed to accompany other ailments and not be the
main reason for hospitalization, (ii) since the bacterial
infection is not the main reason of hospitalization
patients leave the hospital or die at a rate proportional to
their frequency, (iii) hospital occupancy is kept constant,
(iv) there are no double-resistant bacteria in the hospital
initially, and that their frequency in the general popula-
tion is negligible. Concerning the SIM, they also took
into consideration modeling the relative persistence of
antibiotic resistance when there is no direct antibiotic
use. The introduction of different level assumptions
(antibiotic resistance persistence and stress-induced
mutation) has had different consequences in terms of the
proportion of infected patients and emergence of resis-
tance. Indeed, the latter two parameters may vary either
in the same direction or in the opposite direction in func-
tions of the hypotheses. Another mechanism of acquisi-
tion of antibiotic resistance studied in this model was
HGT. The latter was studied in defining an encounter
rate between bacteria. The authors also considered situa-
tions in which the bacteria were or were not under anti-
biotic stress. They developed the notion of time required
for the cellular mechanisms to induce or repress HGT.
They defined an extreme situation where the HGT rates
of bacteria transmitted from patient A to patient B
depend only on the stress of the bacteria experienced
while residing in patient A. Thus, assessing the effects of
different antibiotic regimens with respect to the encoun-
ter rates between bacteria is complex.
Finally, from this complex mathematical model, based
on the important concepts of SIM and HGT, several con-
clusions can be proposed. The authors have shown the
relationship between stress-induced genetic variation and
the emergence of double resistance. Combining performs
very poorly in inhibiting double resistance emergence
when genetic variation is stress induced. Cycling is the
preferred strategy with respect to the acquisition of resis-
tance through SIM. When there is stress-induced HGT,
cycling and mixing are the favored strategies. The speed
of change in HGT frequencies in response to antibiotic
stress determines the choice of strategy between mixing
and cycling. The authors note that their predictions hold
even for very mild increases of HGT and mutation rates
under antibiotic stress in comparison with those
described in the literature. However, the cited publica-
tions were referring to in vitro studies [5-8]
Future directions and conclusions
The present model has shown that combining was
slightly more efficient than mixing and cycling with
regard to minimizing infection. Regarding double resis-
tance emergence, both mixing and cycling were more
efficient than combining when variation is stress
induced.
The authors have described the limits of their work:
they did not consider the possible fitness cost of antibio-
tic resistance or the influence of stochastic events (epi-
demic outbursts of bacteria and extinction of rare
bacterial strains for long periods of time, human errors
in the form of dosage errors, lack of compliance to hos-
pital guidelines) on the dynamics. Other limiting factors
were also mentioned such as patient age, relative effi-
ciency of the different antibiotics and drug interactions.
In our opinion, other limits could also have been men-
tioned: the problems of non-adherence, self-medication,
outpatient antibiotic use, and the state of immunosup-
pression of the patient treated.
Mathematical models such as that built by Obolski
and Hadany are an important step in regulating the con-
sumption of antibiotics. The originality in this model is
the study of stress-induced genetic variation mechan-
isms on resistance emergence and minimization of
infection. However, in the literature, it is usual that
models consider only a single pathogen or a single
mechanism of resistance acquisition and it is not clear
that they can be applied to other clinical situations. At
the same time, with the aim to try to stop the continu-
ing spiral of resistance it is necessary to develop other
research programs: campaigns to educate the public and
healthcare workers [9], novel avenues for drugs targeting
against infectious agents [10,11], the development of
phage strategies [12,13] and new conjugate vaccines
[14], the use of new agents such as probiotics or anti-
virulence drugs [15,16], and the use of new diagnostic
tools to differentiate colonization from infection [17].
Only with a multidisciplinary approach will win the
fight against MDR bacteria.
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